Mylan, lambasted for EpiPen price hikes, complains of overpriced anti-HIV drugs in the United States By Jon CohenAug. 3, 2018
‘It’s sobering’: A once-exciting HIV cure strategy fails its test in people By Jon CohenJul. 25, 2018
Troubling questions remain about whether a popular HIV drug causes birth defects By Jon CohenJul. 24, 2018
